Ross Operation in Pediatric Population: Impact of the Surgical Timing and the Native Pulmonary Diameter on the Outcome.


Journal

Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 22 03 2022
accepted: 09 08 2022
pubmed: 23 8 2022
medline: 3 3 2023
entrez: 22 8 2022
Statut: ppublish

Résumé

Aortic valve replacement early in life may be inevitable. Ross operation, until present day, remains the favorite surgical option in pediatrics with irreparable aortic valve disease. Nonetheless, the necessity for re-operation was always its principal limitation due to aortic valve failure or homograft degeneration. We present our 25 years of experience in the pediatric population. From August 1994 until June 2018, 157 children below 18 years underwent the Ross operation. This retrospective review aims at assessing the long-term outcomes, as well as the risk factors for re-operation after Ross procedure. Median age was 10.9 years, of which seven patients were infants, 79 children, and 71 adolescents. The median follow-up time was 14 years. Hospital mortality was 0.6%. Freedom from autograft re-operation for children was 96.7% and 94.1% at 10 and 20 years, respectively; whereas for adolescents, it was 92.6% and 74.9% at 10 and 20 years. For children, freedom from homograft re-operation was 92.5%, 83.5%, and 56.2% at 10, 15, and 20 years; while for adolescents, it was 96.8%, 91.8%, and 86.7% at 10, 15, and 20 years. Homograft size (p = 0.008) and childhood (p = 0.05) were risk factors for homograft re-operation. Pulmonary valve diameter > 24 mm (p = 0.044) and adolescence (p = 0.032) were risk factors for autograft re-operation. Our experience demonstrated excellent early and late survival. While children have preferential outcomes concerning autograft re-operation, those who received a smaller homograft had a higher right-sided re-intervention incidence than adolescents. Pulmonary diameter > 24 mm at surgery was an indicator of future autograft failure.

Identifiants

pubmed: 35994068
doi: 10.1007/s00246-022-02990-1
pii: 10.1007/s00246-022-02990-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-673

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Ross DN (1967) Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 290:956–958
doi: 10.1016/S0140-6736(67)90794-5
Elkins RC, Thompson DM, Lane MM, Elkins CC, Peyton MD (2008) Ross operation: 16-year experience. J Thorac Cardiovasc Surg 136:623–630
doi: 10.1016/j.jtcvs.2008.02.080 pubmed: 18805263
Takkenberg JJ, Kappetein AP, van Herwerden LA, Witsenburg M, Van Osch-Gevers L, Bogers AJ (2005) Pediatric autograft aortic root replacement: a prospective follow-up study. Ann Thorac Surg 80:1628–1633
doi: 10.1016/j.athoracsur.2005.04.057 pubmed: 16242428
Simon P, Aschauer C, Moidl R et al (2001) Growth of the pulmonary autograft after the Ross operation in childhood. Eur J Cardiothorac Surg 19:118–121
doi: 10.1016/S1010-7940(00)00638-2 pubmed: 11167098
Elkins RC, Knott-Craig CJ, Ward KE, McCue C, Lane MM (1994) Pulmonary autograft in children: realized growth potential. Ann Thorac Surg 57:1387–1393
doi: 10.1016/0003-4975(94)90089-2 pubmed: 8010778
David TE, David C, Woo A, Manlhiot C (2014) The Ross procedure: outcomes at 20 years. J Thorac Cardiovasc Surg 147:85–93
doi: 10.1016/j.jtcvs.2013.08.007 pubmed: 24084276
David TE, Ouzounian M, David CM, Lafreniere-Roula M, Manlhiot C (2019) Late results of the Ross procedure. J Thorac Cardiovasc Surg 157:201–208
doi: 10.1016/j.jtcvs.2018.06.037 pubmed: 30104067
Kirkpatrick E, Hurwitz R, Brown J (2008) A single center’s experience with the Ross procedure in pediatrics. Pediatr Cardiol 29:894–900
doi: 10.1007/s00246-008-9224-1 pubmed: 18401635
Morales DL, Carberry KE, Balentine C, Heinle JS, McKenzie ED, Fraser CD (2008) Selective application of the pediatric Ross procedure minimizes autograft failure. Congenit Heart Dis 3:404–410
doi: 10.1111/j.1747-0803.2008.00221.x pubmed: 19037980
Piccardo A, Ghez O, Gariboldi V et al (2009) Ross and Ross-Konno procedures in infants, children and adolescents: a 13-year experience. J Heart Valve Dis 18:76–82
pubmed: 19301557
Kadner A, Raisky O, Degandt A et al (2008) The Ross procedure in infants and young children. Ann Thorac Surg 85:803–809
doi: 10.1016/j.athoracsur.2007.07.047 pubmed: 18291145
Reece TB, Welke KF, O’Brien S, Grau-Sepulveda MV, Grover FL, Gammie JS (2014) Rethinking the Ross procedure in adults. Ann Thorac Surg 97:175–181
doi: 10.1016/j.athoracsur.2013.07.036 pubmed: 24070703
Nishimura RA, Otto CM, Bonow RO, Carabello BA, ErwinIII JP, Guyton RA et al (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease. Circulation 129:e521–e643
pubmed: 24589853
Frigiola A, Varrica A, Satriano A et al (2010) Neoaortic valve and root complex evolution after Ross operation in infants, children, and adolescents. Surgical and Clinical Outcome REsearch (SCORE) Group. Ann Thorac Surg 90:1278–1285
doi: 10.1016/j.athoracsur.2010.06.077 pubmed: 20868828
Nelson JS, Pasquali SK, Pratt CN et al (2015) Long-term survival and re-intervention after the Ross procedure across the pediatric age spectrum. Ann Thorac Surg 60:2086–2094
doi: 10.1016/j.athoracsur.2015.02.068
Brancaccio G, Polito A, Hoxha S et al (2014) The Ross procedure in patients aged less than 18 years: the midterm results. J Thorac Cardiovasc Surg 147:383–388
doi: 10.1016/j.jtcvs.2013.02.037 pubmed: 23490251
Donald JS, Wallace FRO, Naimo PS et al (2020) Ross operation in children: 23-year experience from a single institution. Ann Thorac Surg 4:1251–1259
doi: 10.1016/j.athoracsur.2019.10.070
Martin E, Laurin C, Jacques F (2019) More than 25 years of experience with the Ross procedure in children: a single-center experience. Ann Thorac Surg 110:638
doi: 10.1016/j.athoracsur.2019.10.093 pubmed: 31881194
Etnel JRG, Grashuis P, Huygens SA (2018) The ross procedure: a systematic review, meta-analysis, and microsimulation. Circ Cardiovasc Qual Outcomes 12:e004748
doi: 10.1161/CIRCOUTCOMES.118.004748
Ruzmetov M, Welke KF, Geiss DM, Buckley K, Fortuna RS (2014) Failed autograft after the Ross procedure in children: management and outcome. Ann Thorac Surg 98:112–118
doi: 10.1016/j.athoracsur.2014.02.038 pubmed: 24725835
Elkins RC, Lane MM, McCue C (1996) Pulmonary autograft re-operation: incidence and management. Ann Thorac Surg 62:450–455
doi: 10.1016/0003-4975(96)00278-0 pubmed: 8694604
David TE, Omran A, Ivanov J et al (2000) Dilation of the pulmonary autograft after the Ross procedure. J Thorac Cardiovasc Surg 119:210–220
doi: 10.1016/S0022-5223(00)70175-9 pubmed: 10649195
Brinkman WT, Herbert MA, Prince SL, Ryan C, Ryan WH (2012) Redo autograft operations after the Ross procedure. Ann Thorac Surg 93:1477–1482
doi: 10.1016/j.athoracsur.2012.01.100 pubmed: 22464553
De Kerchove L, Boodhwani M, Etienne P-Y et al (2010) Preservation of the pulmonary autograft after failure of the Ross procedure. Eur J Cardiothorac Surg 38:326–332
doi: 10.1016/j.ejcts.2010.02.014 pubmed: 20353892
Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, Schoen FJ (2006) Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 113:1344–1352
doi: 10.1161/CIRCULATIONAHA.105.591768 pubmed: 16534030
Matsuzaki Y, Hiramatsu T, Agematsu K, Sakamoto T, Nagashima M, Matsumura G, Niinami H (2019) Long-term outcomes of Ross and Ross-Konno operations in patients under 15 years of age. Gen Thorac Cardiovasc Surg 67:420–426
doi: 10.1007/s11748-018-1034-7 pubmed: 30421385
Shinkawa T, Bove EL, Hirsch JC, Devaney EJ, Ohye RG (2010) Intermediate-term results of the Ross procedure in neonates and infants. Ann Thorac Surg 89:1827–1832
doi: 10.1016/j.athoracsur.2010.02.107 pubmed: 20494035
Bansal N, Kumar SR, Baker CJ, Lemus R, Wells WJ, Starnes VA (2015) Age-related outcomes of the Ross procedure over 20 years. Ann Thorac Surg 99:2077–2083
doi: 10.1016/j.athoracsur.2015.02.066 pubmed: 25921257
Mazine A, El-Hamamsy I, Verma S et al (2018) Ross procedure in adults for cardiologists and cardiac surgeons: JACC state-of-the-art review. J Am Coll Cardiol 72(22):2761–2777
doi: 10.1016/j.jacc.2018.08.2200 pubmed: 30497563
Hörer J, Kasnar-Samprec J, Charitos E et al (2013) Patient age at the Ross operation in children influences aortic root dimensions and aortic regurgitation. World J Pediatr Congenit Heart Surg 3:245–252
doi: 10.1177/2150135113485763
Varrica A, Satriano A, Frigiola A, Giamberti A (2021) Autograft Wrapping Reinforcement in adolescents undergoing ross operation: a tailored coat. Ann Thorac Surg. https://doi.org/10.1016/j.athoracsur.2021.05.087
doi: 10.1016/j.athoracsur.2021.05.087 pubmed: 34217690
Charitos EI, Takkenberg JJ, Hanke T et al (2012) Re-operations on the pulmonary autograft and pulmonary homograft after the Ross procedure: An update on the German Dutch Ross Registry. J Thorac Cardiovasc Surg 144:813–821
doi: 10.1016/j.jtcvs.2012.07.005 pubmed: 22883549
Brown JW, Fehrenbacher JW, Ruzmetov M, Shahriari A, Miller J, Turrentine MW (2011) Ross root dilation in adult patients: is preoperative aortic insufficiency associated with increased late autograft re-operation? Ann Thorac Surg 92(1):74–81
doi: 10.1016/j.athoracsur.2011.02.012 pubmed: 21620370

Auteurs

Alessandro Varrica (A)

Congenital Cardiac Surgery Department, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Policlinico San Donato, Via Morandi 30, San Donato Milanese, 20097, Milan, Italy. a.varrica@virgilio.it.

Alessandro Giamberti (A)

Congenital Cardiac Surgery Department, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Policlinico San Donato, Via Morandi 30, San Donato Milanese, 20097, Milan, Italy.

Mauro Lo Rito (M)

Congenital Cardiac Surgery Department, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Policlinico San Donato, Via Morandi 30, San Donato Milanese, 20097, Milan, Italy.

Matteo Reali (M)

Congenital Cardiac Surgery Department, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Policlinico San Donato, Via Morandi 30, San Donato Milanese, 20097, Milan, Italy.

Mahmood Hafdhullah (M)

Congenital Cardiac Surgery Department, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Policlinico San Donato, Via Morandi 30, San Donato Milanese, 20097, Milan, Italy.

Angela Satriano (A)

Anesthesia and Intensive Care Department, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Antonio Saracino (A)

Pediatric and Adult Congenital Heart Centre, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Angelo Micheletti (A)

Pediatric and Adult Congenital Heart Centre, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Alessandro Frigiola (A)

Congenital Cardiac Surgery Department, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Policlinico San Donato, Via Morandi 30, San Donato Milanese, 20097, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH